The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
March 1977 (Volume 55)
Quarterly Article
John K. Iglehart
Nov 5, 2024
Oct 30, 2024
Oct 23, 2024
Back to The Milbank Quarterly
One of the key elements of the medical care cost spiral is the proliferation of high-cost medical technologies. At their life-saving extreme, there are no services society values more; at their cost-generating extreme, governmental concern looms large. Three laws are already on the books that will affect the development and diffusion of technology through direct regulation. Formal-and revealingly informal-policy processes are creating further mechanisms by which government will assess current medical treatment practices, procedures, and technologies. These assessments are likely to be used in deciding which services will be paid for under Medicare, Medicaid and, eventually, national health insurance.
Author(s): John K. Iglehart
Download the Article
Read on JSTOR
Volume 55, Issue 1 (pages 25–59) Published in 1977
